Prof.Dr. Subklewe includes the MIRACLE Doctoral Network in her presentation.

Acute Leukemias XIX (ISALXIX), the hematology event in spring 2025 for all healthcare professionals active in the field of acute leukemias, took place in Munich, Germany from 16-19 March.

A big thank you to Univ.-Prof. Dr. med. Marion Subklewe, Ludwig-Maximilians-Universität München, for informing the conference attendees about the MIRACLE MSCA project.

Prof.Dr. Subklewe is PI for the MIRACLE Research Project DC10 titled "Targeting MRD and LSCs in the bone marrow niche by chemokine modified, dual targeting CAR T cells in AML". Read more about the project >